BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7862703)

  • 1. Atipamezole, an alpha 2 antagonist, augments opiate-induced muscle rigidity in the rat.
    Weinger MB; Bednarczyk JM
    Pharmacol Biochem Behav; 1994 Nov; 49(3):523-9. PubMed ID: 7862703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for CNS alpha-2 adrenergic receptors in opiate-induced muscle rigidity in the rat.
    Weinger MB; Chen DY; Lin T; Lau C; Koob GF; Smith NT
    Brain Res; 1995 Jan; 669(1):10-8. PubMed ID: 7712151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexmedetomidine, acting through central alpha-2 adrenoceptors, prevents opiate-induced muscle rigidity in the rat.
    Weinger MB; Segal IS; Maze M
    Anesthesiology; 1989 Aug; 71(2):242-9. PubMed ID: 2569282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of central mu, delta-1, and kappa-1 opioid receptors in opioid-induced muscle rigidity in the rat.
    Vankova ME; Weinger MB; Chen DY; Bronson JB; Motis V; Koob GF
    Anesthesiology; 1996 Sep; 85(3):574-83. PubMed ID: 8853088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrous oxide produces a biphasic effect on opiate-induced muscle rigidity in the rat.
    Chang NJ; Weinger MB; Dyck JB
    Pharmacol Biochem Behav; 1995 Mar; 50(3):351-8. PubMed ID: 7617673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonist effects of beta-funaltrexamine and naloxonazine on alfentanil-induced antinociception and muscle rigidity in the rat.
    Negus SS; Pasternak GW; Koob GF; Weinger MB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):739-45. PubMed ID: 8437122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment with sedative-hypnotics, but not with nondepolarizing muscle relaxants, attenuates alfentanil-induced muscle rigidity.
    Sanford TJ; Weinger MB; Smith NT; Benthuysen JL; Head N; Silver H; Blasco TA
    J Clin Anesth; 1994; 6(6):473-80. PubMed ID: 7880510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain sites mediating opiate-induced muscle rigidity in the rat: methylnaloxonium mapping study.
    Weinger MB; Smith NT; Blasco TA; Koob GF
    Brain Res; 1991 Mar; 544(2):181-90. PubMed ID: 2039935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketanserin pretreatment reverses alfentanil-induced muscle rigidity.
    Weinger MB; Cline EJ; Smith NT; Koob GF
    Anesthesiology; 1987 Sep; 67(3):348-54. PubMed ID: 3115150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in diaphragm EMG activity during opiate-induced respiratory depression.
    Campbell C; Weinger MB; Quinn M
    Respir Physiol; 1995 May; 100(2):107-17. PubMed ID: 7624612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of dose-effect relationships for different opiate effects using alfentanil in the spontaneously ventilating rat.
    Yang PK; Weinger MB; Negus SS
    Anesthesiology; 1992 Jul; 77(1):153-61. PubMed ID: 1609989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripherally administered alpha2-adrenoceptor agonist in the modulation of chronic allodynia induced by spinal nerve ligation in the rat.
    Wei H; Pertovaara A
    Anesth Analg; 1997 Nov; 85(5):1122-7. PubMed ID: 9356112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atipamezole-precipitated clonidine withdrawal induces c-Fos expression in rat central nervous system.
    Stornetta RL; Grubb MC; Guyenet PG
    Brain Res; 1997 Aug; 764(1-2):81-92. PubMed ID: 9295196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a selective alpha2-adrenoceptor antagonist on pain behavior of the rat varies, depending on experimental parameters.
    Kauppila T; Jyväsjärvi E; Hämäläinen MM; Pertovaara A
    Pharmacol Biochem Behav; 1998 Feb; 59(2):477-85. PubMed ID: 9476998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine, a selective alpha 2-agonist, does not potentiate the cardiorespiratory depression of alfentanil in the rat.
    Furst SR; Weinger MB
    Anesthesiology; 1990 May; 72(5):882-8. PubMed ID: 1971163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.
    Haapalinna A; Leino T; Heinonen E
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):342-51. PubMed ID: 14566451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers.
    Scheinin H; Aantaa R; Anttila M; Hakola P; Helminen A; Karhuvaara S
    Anesthesiology; 1998 Sep; 89(3):574-84. PubMed ID: 9743392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of brainstem sites which mediate alfentanil-induced muscle rigidity in the rat.
    Weinger MB; Cline EJ; Smith NT; Blasco TA; Koob GF
    Pharmacol Biochem Behav; 1988 Mar; 29(3):573-80. PubMed ID: 3129743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist.
    Pertovaara A; Haapalinna A; Sirviö J; Virtanen R
    CNS Drug Rev; 2005; 11(3):273-88. PubMed ID: 16389294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats.
    Wardas J; Konieczny J; Lorenc-Koci E
    Synapse; 2001 Aug; 41(2):160-71. PubMed ID: 11400182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.